Study on the pharmacokinetics and safety of compound aluminum sulfate injection in rabbits

Feng-Hua XU,Xue-Qin JIANG,Feng GU,Yi FANG,Xiu-Yun GAO
DOI: https://doi.org/10.3969/j.issn.1671-2838.2006.03.009
2006-01-01
Pharmaceutical Care and Research
Abstract:Objective: To study the pharmacokinetics of compound aluminum sulfate injection after iv injection in rabbits and its absorption after im injection. Methods: Compound aluminum sulfate injection 1 mg/kg was injected iv to the left-ear or 80 mg/kg im in femoral quadriceps. Blood samples were collected at different time points after injection from the right-ear vein. ICP-MS assay was used to determine the aluminum concentration. Pharmacokinetic parameters were calculated with DAS program. The clinical biochemical analyses were conducted with an automatic analyzer. Results: The blood aluminum concentration-time profiles after iv injection of 1 mg/kg aluminum sulfate fitted to a two-compartment model, with t 1/2β (1.08±0.46) h and AUC 0→24h (1.52±0.92) mg · h · L -1 (n=5). A little elevation of blood aluminum concentration was seen after im injection of 80 mg/kg aluminum sulfate. The average AUC 0→24h was (2.93±1.82) mg · h · L -1 (n=5) and bioavailability was only 2.41%. Except for an occasional elevation of alanine aminotransferase in both groups and a slow decrease in creatinine level in im group, no obvious changes in the serum levels of clinical biochemical parameters were seen after drug administration. Conclusion: Compound aluminum sulfate injection is a safe preparation which is poorly absorbed after im injection.
What problem does this paper attempt to address?